Neural Analytics Inc. raised $10 million to back the commercialization of its portable ultrasound Lucid System that's intended to better enable first responders and health care providers to measure, diagnose and track brain disorders including stroke and traumatic brain injury.

Technology to enable paralyzed patients to move, and even to feel, their limbs is advancing apace. The latest progress comes from Case Western Reserve University researchers who have worked for months with a man with quadriplegia to enable him to raise a mug to his own lips to sip through a straw.

Shares of Novocure Ltd. (NASDAQ:NVCR) got a boost last week – jumping 37 percent Monday – on a slew of data presented at the American Association for Cancer Research meeting in Washington, including final pivotal results in newly diagnosed glioblastoma (GBM) that included five-year survival data for its Optune device. That could help improve the status of the technology with payers and physicians, whose embrace hasn’t been uniform thus far.

Diagnostics player Cancer Genetics Inc. (CGI) has paired up with artificial intelligence (AI) company Mendel Health to incorporate deep learning into clinical trial matching.

Boston Scientific Corp. will acquire Symetis SA for $435 million in cash in an effort to broaden its transcatheter aortic valve replacement (TAVR) portfolio. The Ecublens, Switzerland-based company had been expected to list publicly at the end of this month on the Euronext Paris market in an offering slated to raise €55.8 million (US$59.9 million). Instead, the Marlborough, Mass., cardiovascular giant has scooped up Symetis, which has two EU marketed TAVRs with a next-gen iteration in the clinic. Wall Street evinced some concern that the addition of Symetis' Acurate platform to Boston Scientific's existing Lotus...